Core Viewpoint - Jilin Aodong's stock price has shown significant growth this year, with a 20.41% increase, and the company is actively involved in various sectors including traditional Chinese medicine and health products [1][2]. Financial Performance - For the first half of 2025, Jilin Aodong reported a revenue of 1.126 billion yuan, a year-on-year decrease of 20.21%, while the net profit attributable to shareholders was 1.282 billion yuan, reflecting a year-on-year increase of 138.44% [2]. - Cumulative cash dividends since the company's A-share listing amount to 4.43 billion yuan, with 1.647 billion yuan distributed over the past three years [3]. Stock Market Activity - As of October 9, Jilin Aodong's stock price was 20.44 yuan per share, with a market capitalization of 24.444 billion yuan. The stock has seen a trading volume of 292 million yuan and a turnover rate of 1.23% [1]. - The stock has experienced a net inflow of 8.2328 million yuan from main funds, with significant buying and selling activity noted [1]. Shareholder Structure - As of June 30, 2025, the number of shareholders decreased to 66,000, with an average of 18,059 circulating shares per person, an increase of 1.62% [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited and Southern CSI 500 ETF, with notable increases in their holdings [3].
吉林敖东涨2.15%,成交额2.92亿元,主力资金净流入823.28万元